Evaluate Bioequivalence of Micafungin (50mg/Vial)

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05763251` - Comparison of Uncomplicated Candidemia Therapy Duration in Children	N/A
Recruiting	`NCT01438216` - Anidulafungin Pharmacokinetics in Intensive Care Unit Patients	N/A
Terminated	`NCT01213823` - Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins	Phase 4
Completed	`NCT02491151` - Variability of Fluconazole Concentration in Critically Ill Patients	N/A
Completed	`NCT01716988` - Pharmacokinetics of Micafungin in Critically Ill Patients	N/A
Completed	`NCT00607763` - Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Phase 1
Completed	`NCT00608335` - Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Phase 1
Completed	`NCT00786903` - Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?	N/A
Completed	`NCT00670657` - CRITIC - Treatment of Candidemia and Invasive Candidiasis	Phase 4
Recruiting	`NCT04368559` - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation	Phase 3
Not yet recruiting	`NCT05707832` - A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus	Phase 3
Recruiting	`NCT03538912` - Early Discontinuation of Empirical Antifungal Therapy and Biomarkers	N/A
Completed	`NCT02801682` - NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
Completed	`NCT02164890` - Pharmacokinetics of Micafungin in Patients of Intensive Care Units	Phase 4
Completed	`NCT02841501` - Genetic Susceptibility Factors for Candidemia.
Completed	`NCT01047267` - Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)	N/A
Completed	`NCT00672841` - β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients	N/A
Completed	`NCT02734862` - CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension	Phase 2
Completed	`NCT01773876` - Empirical Antifungal Treatment in ICUS	Phase 3
Completed	`NCT00689338` - Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study	Phase 3

NCT number	NCT05496725
Study type	Interventional
Source	Yung Shin Pharm. Ind. Co., Ltd.
Contact
Status	Completed
Phase	Phase 4
Start date	January 6, 2022
Completion date	July 28, 2022

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms